Twist Bioscience Corporation Sustainability Profile
Twist Bioscience Corporation, commonly referred to as Twist Bioscience, is a pioneering synthetic biology company headquartered in the United States. Founded in 2013, the company has rapidly established itself as a leader in the biotechnology sector, focusing on DNA synthesis and gene editing technologies. With major operational regions across North America and Europe, Twist Bioscience serves a diverse range of industries, including pharmaceuticals, agriculture, and industrial biotechnology. The company’s core offerings include high-quality, scalable DNA synthesis solutions that are distinguished by their precision and efficiency. Twist Bioscience's innovative approach to DNA manufacturing has garnered significant recognition, positioning it as a key player in the synthetic biology market. Notable achievements include partnerships with leading research institutions and a commitment to advancing genetic research, making Twist Bioscience a vital contributor to the future of biotechnology.
DitchCarbon Score
How does Twist Bioscience Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Twist Bioscience Corporation's score of 30 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Twist Bioscience Corporation's reported carbon emissions
Twist Bioscience Corporation, headquartered in the United States, currently does not report any specific carbon emissions data for the latest year. However, the company is committed to addressing climate change through various initiatives. Twist Bioscience has made a near-term commitment to reduce its carbon footprint, as indicated by its participation in the Science Based Targets initiative (SBTi). While specific reduction targets have not been disclosed, the company is actively engaged in setting measurable goals to mitigate its environmental impact. As part of the pharmaceuticals, biotechnology, and life sciences sector, Twist Bioscience is aware of the industry's responsibility to reduce greenhouse gas emissions. The company is focused on sustainability and is expected to align its practices with industry standards for climate action. Overall, while specific emissions data is not available, Twist Bioscience's commitment to climate initiatives reflects a proactive approach to environmental stewardship.
How Carbon Intensive is Twist Bioscience Corporation's Industry?
How Carbon Intensive is Twist Bioscience Corporation's Location?
Twist Bioscience Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Twist Bioscience Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
